Published in Ann Otolaryngol Chir Cervicofac on December 01, 1980
Endoscopic cordectomy. A proposal for a classification by the Working Committee, European Laryngological Society. Eur Arch Otorhinolaryngol (2000) 1.76
Detection of plasma tumor DNA in head and neck squamous cell carcinoma by microsatellite typing and p53 mutation analysis. Cancer Res (2000) 1.63
p53 alterations predict tumor response to neoadjuvant chemotherapy in head and neck squamous cell carcinoma: a prospective series. J Clin Oncol (2000) 1.39
A clinical trial of continuous cisplatin-fluorouracil induction chemotherapy and supracricoid partial laryngectomy for glottic carcinoma classified as T2. Cancer (1994) 1.39
Supracricoid laryngectomy with cricohyoidoepiglottopexy: a partial laryngeal procedure for glottic carcinoma. Ann Otol Rhinol Laryngol (1990) 1.16
Supracricoid laryngectomy with cricohyoidopexy: a partial laryngeal procedure for selected supraglottic and transglottic carcinomas. Laryngoscope (1990) 1.14
Chemotherapy alone with curative intent in patients with invasive squamous cell carcinoma of the pharyngolarynx classified as T1-T4N0M0 complete clinical responders. Cancer (2001) 1.05
[Advanced carcinoma of the oropharynx: the value of induction chemotherapy before locoregional treatment. A retrospective study of 138 cases]. Bull Cancer (1988) 1.05
Total conservative parotidectomy for primary benign pleomorphic adenoma of the parotid gland: a 25-year experience with 229 patients. Laryngoscope (1994) 1.04
Expression and mutational status of treatment-relevant targets and key oncogenes in 123 malignant salivary gland tumours. Ann Oncol (2013) 1.03
Glutathione-associated enzymes in head and neck squamous cell carcinoma and response to cisplatin-based neoadjuvant chemotherapy. Int J Cancer (2001) 1.01
Cisplatin-fluorouracil exclusive chemotherapy for T1-T3N0 glottic squamous cell carcinoma complete clinical responders: five-year results. J Clin Oncol (1996) 0.99
Transoral robotic surgery in head and neck cancer. Eur Ann Otorhinolaryngol Head Neck Dis (2011) 0.97
Head and neck pilomatrixoma. Am J Otolaryngol (1996) 0.97
Supracricoid partial laryngectomy for non-squamous cell carcinoma of the larynx. J Laryngol Otol (2001) 0.95
Esophageal diverticulum: diverticulopexy versus diverticulectomy. Laryngoscope (1994) 0.94
Supracricoid partial laryngectomy after failed laryngeal radiation therapy. Laryngoscope (1996) 0.94
Glottic carcinoma with a fixed true vocal cord: outcomes after neoadjuvant chemotherapy and supracricoid partial laryngectomy with cricohyoidoepiglottopexy. Otolaryngol Head Neck Surg (1996) 0.94
Complications and functional outcome after supracricoid partial laryngectomy with cricohyoidoepiglottopexy. Otolaryngol Head Neck Surg (1998) 0.94
Aspiration in unilateral recurrent laryngeal nerve paralysis after surgery. Am J Otolaryngol (1998) 0.93
Frequent allelic loss at chromosome 3p distinct from genetic alterations of the 8-oxoguanine DNA glycosylase 1 gene in head and neck cancer. Mol Carcinog (1999) 0.93
Madreporic coral: a new bone graft substitute for cranial surgery. J Neurosurg (1988) 0.91
[Proboscis lateralis, a rare facial malformation. Therapeutic difficulties (apropos of a case)]. Ann Otolaryngol Chir Cervicofac (1983) 0.90
In situ lifetime, causes for replacement, and complications of the Provox voice prosthesis. Laryngoscope (1997) 0.90
Clinicopathological significance of mitochondrial D-Loop mutations in head and neck carcinoma. Br J Cancer (2006) 0.89
Implantation metastasis following percutaneous endoscopic gastrostomy. J Laryngol Otol (1993) 0.88
Solitary fibrous tumour of the larynx: report of a case. J Laryngol Otol (1998) 0.88
Cricohyoidoepiglottopexy for glottic carcinoma with fixation or impaired motion of the true vocal cord: 5-year oncologic results with 112 patients. Ann Otol Rhinol Laryngol (1997) 0.88
Cavernous sinus involvement from recurrent adenoid cystic carcinoma. Ann Otol Rhinol Laryngol (1994) 0.88
Supracricoid partial laryngectomy with cricohyoidoepiglottopexy for "early" glottic carcinoma classified as T1-T2N0 invading the anterior commissure. Am J Otolaryngol (1998) 0.87
Giant tonsillolith. Ann Otol Rhinol Laryngol (1998) 0.86
Supracricoid partial laryngectomies in the elderly: mortality, complications, and functional outcome. Laryngoscope (1998) 0.86
[Castleman's disease. Report of 2 cases with otorhinolaryngologic involvement]. Ann Otolaryngol Chir Cervicofac (1990) 0.86
Extended supracricoid partial laryngectomy with tracheocricohyoidoepiglottopexy. Acta Otolaryngol (1994) 0.86
Bacteriology of the adult middle meatus. J Laryngol Otol (1996) 0.86
Biodegradable starch microspheres for cerebral arterial embolization. Invest Radiol (1993) 0.85
Complications of postoperative radiation therapy after partial laryngectomy in supraglottic cancer: A long-term evaluation. Otolaryngol Head Neck Surg (2000) 0.85
Normal laryngeal CT findings after supracricoid partial laryngectomy. AJNR Am J Neuroradiol (2001) 0.85
Neo-adjuvant chemotherapy and supracricoid partial laryngectomy with cricohyoidopexy for advanced endolaryngeal carcinoma classified as T3-T4: 5-year oncologic results. Head Neck (1998) 0.85
[Partial supracricoid laryngectomy. Technics, indications and results]. Ann Otolaryngol Chir Cervicofac (1987) 0.84
[Malignant ethmoid-sphenoidal tumors. 130 cases. Retrospective study]. Neurochirurgie (1997) 0.84
Cricotracheal anastomosis for assisted ventilation-induced stenosis. Arch Otolaryngol Head Neck Surg (1997) 0.84
New surgical obturator prosthesis for hemimaxillectomy patients. J Prosthet Dent (1993) 0.84
Recurrent gustatory sweating (Frey syndrome) after intracutaneous injection of botulinum toxin type A: incidence, management, and outcome. Arch Otolaryngol Head Neck Surg (1999) 0.84
Supracricoid hemilaryngopharyngectomy. Analysis of 240 cases. Ann Otol Rhinol Laryngol (1987) 0.83
Further experience with the myomucosal tracheoesophageal shunt. Arch Otolaryngol Head Neck Surg (1988) 0.83
[Supra-cricoid partial laryngectomy extended to the anterior arch of the cricoid with tracheo-crico-hyoido-epiglottopexy. Oncologic and functional results]. Ann Otolaryngol Chir Cervicofac (1996) 0.83
Cortical perfusion response to an electrical stimulation of the auditory nerve in profoundly deaf patients: study with technetium-99m hexamethylpropylene amine oxime single photon emission tomography. Eur J Nucl Med (1992) 0.83
Functional outcome and prognosis factors after supracricoid partial laryngectomy with cricohyoidopexy. Ann Otol Rhinol Laryngol (1997) 0.83
[Repeat of lymphatic dissection for thyroid cancers]. Ann Otolaryngol Chir Cervicofac (2009) 0.83
Vertical partial laryngectomy: a critical analysis of local recurrence. Ann Otol Rhinol Laryngol (1991) 0.83
Soluble interleukin-2 receptor and metalloproteinase-9 expression in head and neck cancer: prognostic value and analysis of their relationships. Clin Exp Immunol (2007) 0.82
Long-term results after esophagectomy for squamous cell carcinoma of the esophagus associated with head and neck cancer. Am J Surg (1999) 0.82
Increment of brain temporal perfusion during auditory stimulation. Preliminary study with technetium-99m HMPAO SPET. Eur J Nucl Med (1991) 0.82
[Reconstruction of the anterior face of the base of the skull using coral grafts]. Neurochirurgie (1988) 0.82
[Contribution and limits of acoustic analysis of the voice and alaryngeal speech with a computerized system]. Ann Otolaryngol Chir Cervicofac (1996) 0.82
A multimodal strategy for the treatment of patients with T2 invasive squamous cell carcinoma of the glottis. Cancer (1999) 0.81
[Study of a series of 158 parotidectomies and histological problems in mixed tumors of salivary glands (author's transl)]. Ann Otolaryngol Chir Cervicofac (1979) 0.81
Experience in the treatment of synchronous and metachronous carcinoma of the oesophagus and the head and neck. J Surg Oncol (2000) 0.81
[Partial posterior cordectomy with laser CO2 in bilateral recurrent paralysis]. Ann Otolaryngol Chir Cervicofac (1992) 0.81
Laryngofissure and cordectomy for glottic carcinoma limited to the mid third of the mobile true vocal cord. Laryngoscope (1997) 0.81
[Metastasis of renal carcinoma to the thyroid gland]. Ann Otolaryngol Chir Cervicofac (2007) 0.81
[Fronto-naso-ethmoido-sphenoido-maxillo-orbital mucocele with ophthalmologic presentation]. J Fr Ophtalmol (1999) 0.80
[Malignant transformation of inverted papilloma of the nasal sinuses.. Apropos of a series of 7 cases]. Ann Otolaryngol Chir Cervicofac (1994) 0.80
[Intelligibility of French consonants after partial supra-cricoid laryngectomy]. Rev Laryngol Otol Rhinol (Bord) (2002) 0.80
[Deglutition and partial supracricoid laryngectomies]. Ann Otolaryngol Chir Cervicofac (1992) 0.79
Esthesioneuroblastoma. Complete tumor response after induction chemotherapy. Ear Nose Throat J (1990) 0.79
CO2 laser endoscopic posterior partial transverse cordotomy for bilateral paralysis of the vocal fold. Laryngoscope (1999) 0.79
Local failure after supracricoid partial laryngectomy: symptoms, management, and outcome. Laryngoscope (1998) 0.79
Brainstem auditory evoked responses in patients with tinnitus. Audiology (1997) 0.79
Duration and frequency characteristics of speech and voice following supracricoid partial laryngectomy. Ann Otol Rhinol Laryngol (1995) 0.79
Intrinsic infiltrating intramuscular laryngeal lipoma. Otolaryngol Head Neck Surg (1995) 0.79
Cholesterol granuloma of the maxillary sinus. Rev Laryngol Otol Rhinol (Bord) (2010) 0.79
[Tumors of the nasal fossa. Retrospective study of a series of 67 cases]. Ann Otolaryngol Chir Cervicofac (1989) 0.79
Silent gastroesophageal reflux disease in patients with pharyngolaryngeal cancer: further results. Head Neck (1998) 0.79
Carcinoid (neuroendocrine) tumor of the arytenoid. Arch Otolaryngol Head Neck Surg (1991) 0.78
[Chemotherapy and partial surgery in epithelioma of the pharyngo-larynx]. Ann Otolaryngol Chir Cervicofac (1988) 0.78